Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2010 1
2011 1
2012 1
2013 8
2014 5
2015 13
2016 7
2017 10
2018 7
2019 20
2020 47
2021 40
2022 42
2023 35
2024 20
2025 22
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

249 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Sharma A, Gemmy Cheung CM, Arias-Barquet L, Ozdek S, Parachuri N, Kumar N, Hilely A, Zur D, Loewenstein A, Vella G, Bandello F, Querques G. Sharma A, et al. Among authors: kumar n. Retina. 2022 Mar 1;42(3):e20-e22. doi: 10.1097/IAE.0000000000003366. Retina. 2022. PMID: 34861660 No abstract available.
Brolucizumab in polypoidal choroidal vasculopathy.
Sharma A, Parachuri N, Kumar N, Kuppermann BD, Loewenstein A, Bandello F. Sharma A, et al. Among authors: kumar n. Expert Opin Biol Ther. 2022 Jul;22(7):809-812. doi: 10.1080/14712598.2022.2094239. Epub 2022 Jun 27. Expert Opin Biol Ther. 2022. PMID: 35737884 No abstract available.
Brolucizumab: the road ahead.
Sharma A, Kumar N, Bandello F, Kuppermann BD, Loewenstein A, Regillo CD. Sharma A, et al. Among authors: kumar n. Br J Ophthalmol. 2020 Dec;104(12):1631-1632. doi: 10.1136/bjophthalmol-2020-317528. Epub 2020 Aug 22. Br J Ophthalmol. 2020. PMID: 32829303 No abstract available.
Brolucizumab and immunogenicity.
Sharma A, Kumar N, Parachuri N, Sharma R, Bandello F, Kuppermann BD, Loewenstein A. Sharma A, et al. Among authors: kumar n. Eye (Lond). 2020 Oct;34(10):1726-1728. doi: 10.1038/s41433-020-0853-9. Epub 2020 Apr 6. Eye (Lond). 2020. PMID: 32251366 Free PMC article. No abstract available.
Immunogenicity: Clouding the Future of Intravitreal Therapy.
Sharma A, Kumar N, Parachuri N, Bandello F, Kuppermann BD. Sharma A, et al. Among authors: kumar n. Ocul Immunol Inflamm. 2023 Nov;31(9):1746-1749. doi: 10.1080/09273948.2022.2139273. Epub 2022 Nov 4. Ocul Immunol Inflamm. 2023. PMID: 36332149 No abstract available.
CD2 expressing innate lymphoid and T cells are critical effectors of immunopathogenesis in hidradenitis suppurativa.
Kashyap MP, Mishra B, Sinha R, Jin L, Gou Y, Kumar N, Goliwas KF, Haque S, Deshane J, Berglund E, Berglund D, Elewski BE, Elmets CA, Athar M, Mukhtar MS, Raman C. Kashyap MP, et al. Among authors: kumar n. Proc Natl Acad Sci U S A. 2024 Nov 26;121(48):e2409274121. doi: 10.1073/pnas.2409274121. Epub 2024 Nov 19. Proc Natl Acad Sci U S A. 2024. PMID: 39560648 Free PMC article.
Recurrent hypokalemic paralysis in hypothyroidism.
Singh J, Dinkar A, Kumar N, Kumar K. Singh J, et al. Among authors: kumar n. Am J Med Sci. 2023 May;365(5):462-469. doi: 10.1016/j.amjms.2023.01.009. Epub 2023 Feb 6. Am J Med Sci. 2023. PMID: 36754148 Review.
249 results